van Amelsvoort Ludovic G P M, Slangen Jos J M, Tsai Shan P, de Jong Geert, Kant Ijmert
Department of Epidemiology, School for Public Health and Primary Care Caphri, Maastricht University, Maastricht, The Netherlands.
Int Arch Occup Environ Health. 2009 Jan;82(2):217-25. doi: 10.1007/s00420-008-0325-1. Epub 2008 Apr 22.
Dieldrin and aldrin, pesticides widely used until the 1970s, have been under suspicion of being carcinogenic. In this study, overall and cause-specific mortality was assessed in a cohort of 570 employees occupationally exposed to the pesticides dieldrin and aldrin to investigate the long-term health effects, in particular carcinogenic effects.
All of the employees worked in the production plants between January 1954 and January 1970 and were followed for cause-specific mortality until 30 April 2006. Based on dieldrin levels in blood samples taken from 343 workers during the exposure period, the total intake of dieldrin was estimated for each individual subjects in the cohort. The estimated total intake ranged from 11 to 7,755 mg of dieldrin, with an average of 737 mg.
Two hundred and twenty-six workers had died before 30 April 2006 compared with an expected number of 327.3, giving a standardized mortality ratio (SMR) of 69.0 (95% confidence interval (CI): 60.3-78.7). Overall cancer mortality was also significantly lower than expected (SMR: 76.4, 95% CI: 60.8-94.9). Also, none of the specific cancer sites showed a significant excess mortality and no association between exposure level and cancer mortality was found.
The results from this study support findings from other epidemiological and recent animal studies concluding that dieldrin and aldrin are not likely human carcinogens.
狄氏剂和艾氏剂是直到20世纪70年代仍被广泛使用的农药,一直被怀疑具有致癌性。在本研究中,对570名职业接触狄氏剂和艾氏剂的员工队列进行了全因死亡率和特定病因死亡率评估,以调查其长期健康影响,尤其是致癌作用。
所有员工于1954年1月至1970年1月期间在生产工厂工作,并随访特定病因死亡率直至2006年4月30日。根据暴露期间从343名工人采集的血样中的狄氏剂水平,估算了队列中每个个体受试者的狄氏剂总摄入量。估算的总摄入量范围为11至7755毫克狄氏剂,平均为737毫克。
到2006年4月30日,已有226名工人死亡,而预期死亡人数为327.3人,标准化死亡比(SMR)为69.0(95%置信区间(CI):60.3 - 78.7)。总体癌症死亡率也显著低于预期(SMR:76.4,95%CI:60.8 - 94.9)。此外,没有任何特定癌症部位显示出显著的超额死亡率,并且未发现暴露水平与癌症死亡率之间存在关联。
本研究结果支持其他流行病学研究和近期动物研究的结果,即狄氏剂和艾氏剂不太可能是人类致癌物。